The Virchow GrossBot is robotic system integrated with advanced computer vision to automate the gross examination of small biopsy specimens. It is engineered to perform the most repetitive and error-prone steps of the grossing process, including container handling, tissue orientation, measurement, image capture, and description generation.
Virchow addresses workforce shortages, preanalytical variability, and bottlenecks in pathology labs by offering a scalable, always-on solution built for modern histopathology workflows.
Key Technical Features
🤖 Robotic Automation System
Automated lid removal and specimen retrieval from formalin containers
Gentle tissue handling via precision-guided manipulators
Multi-angle macro imaging for documentation and review
🧠 AI-Powered VirchowVision Engine
Trained on thousands of biopsy images
Identifies tissue fragments, estimates dimensions.
Outputs structured gross descriptions in standardized terminology
🧾 Smart Gross Description Generation
AI converts visual data into structured gross dictation
Optional LIMS export in HL7 or PDF format Supports specimen types: GI biopsies, endometrial samples, skin shaves, etc.
🔄 24/7 Workflow Integration
Designed for continuous operation across multiple shifts
Modular build allows multiple units to operate in parallel
Compatible with standard grossing stations and pathology information systems
System Architecture
Hardware: Robotic arm, precision stage, HD macro camera, touch-safe gripper
Software: Embedded Linux control layer + cloud-hosted AI inference pipeline
Data: Encrypted images and metadata stored locally or securely transmitted to LIMS
Interface: Touchscreen UI, barcode scanner, remote dashboard.
Regulatory Pathway
Current use: Non-diagnostic/research only (for pilot validation)
Roadmap: CLIA-compliant use as a Class I exempt device (automation support tool)
Opportunities for Partners
Pilot Collaboration
Receive early access, co-develop features, and shape real-world use cases
Strategic Investment
Equity opportunities for partner labs and stakeholders
Data Collaboration
Joint research publications and clinical AI validation
Contact
Ifeanyi Victor Nwadukwe, MD, FCAP
Founder, NCRatio, Inc.
Novo Pathology Insights
